Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Farid L. Khan"'
Autor:
Abby E. Rudolph, Farid L. Khan, Tanya G. Singh, Srinivas Rao Valluri, Laura A. Puzniak, John M. McLaughlin
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 9, Pp 2035-2052 (2024)
Abstract Introduction Although real-world studies demonstrate that those prescribed nirmatrelvir/ritonavir (and particularly within 5 days of symptom onset) are less likely to experience severe COVID-19 outcomes, prior studies show that only a small
Externí odkaz:
https://doaj.org/article/e054eaf1567e4fc8aa96a7d8270415d7
Publikováno v:
Open Forum Infectious Diseases. 9
Background Adult respiratory syncytial virus (RSV) vaccines are in late stages of development. A comprehensive synthesis of adult RSV burden is needed to inform public health decision-making. Methods We performed a systematic review and meta-analysis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1905521e74b6359b37a66c1906f355d2
https://doi.org/10.1093/ofid/ofac492.1827
https://doi.org/10.1093/ofid/ofac492.1827
Autor:
Farid L, Khan, Jennifer L, Nguyen, Tanya G, Singh, Laura A, Puzniak, Timothy L, Wiemken, Joshua P, Schrecker, Michael S, Taitel, Joann M, Zamparo, Luis, Jodar, John M, McLaughlin
Publikováno v:
JAMA Network Open. 5:e2246915
ImportanceData describing the vaccine effectiveness (VE) and durability of BNT162b2 among children 5 to 11 years of age are needed.ObjectiveTo estimate BNT162b2 VE against SARS-CoV-2 infection among children aged 5 to 11 years during Delta and Omicro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e287b30678648c9326e1194aa2f0643
https://doi.org/10.1001/jamanetworkopen.2022.46915
https://doi.org/10.1001/jamanetworkopen.2022.46915
Autor:
Kathleen M Andersen, Farid L Khan, Peter W Park, Timothy L Wiemken, Birol Emir, Deepa Malhotra, Tuka Alhanai, Mohammad M Ghassemi, Leah J McGrath
Publikováno v:
PLoS ONE, Vol 19, Iss 4, p e0300570 (2024)
ObjectiveTo create a data-driven definition of post-COVID conditions (PCC) by directly measure changes in symptomatology before and after a first COVID episode.Materials and methodsRetrospective cohort study using Optum® de-identified Electronic Hea
Externí odkaz:
https://doaj.org/article/29538892b8224882afb50500571d2334